Compare SIBN & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIBN | TRNS |
|---|---|---|
| Founded | 2008 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.8M | 861.5M |
| IPO Year | 2018 | 1995 |
| Metric | SIBN | TRNS |
|---|---|---|
| Price | $17.18 | $87.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $23.88 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 639.0K | 152.8K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.33 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | $67,301,000.00 | ★ $331,877,000.00 |
| Revenue This Year | $16.95 | $21.75 |
| Revenue Next Year | $14.93 | $7.55 |
| P/E Ratio | ★ N/A | $151.04 |
| Revenue Growth | ★ 21.53 | 19.20 |
| 52 Week Low | $11.48 | $50.23 |
| 52 Week High | $21.89 | $95.22 |
| Indicator | SIBN | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 46.70 |
| Support Level | $16.42 | $85.90 |
| Resistance Level | $19.79 | $94.58 |
| Average True Range (ATR) | 0.74 | 3.89 |
| MACD | -0.10 | -0.73 |
| Stochastic Oscillator | 42.86 | 21.81 |
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.